A practice can build interview capacity or buy it white-labeled. Building suits a stable baseline; buying suits peaks, because idle researchers between deals cost more than a premium on the deals themselves. What buying costs you is sector familiarity.
What is white-label research?
Research conducted by a third party and delivered under the commissioning firm's name. In diligence it usually covers expert recruitment and interviewing, with analysis and the client relationship retained in-house.
The division matters. Outsourcing execution is a capacity decision; outsourcing the definition of who counts as an expert is a capability decision, and they are frequently conflated.
The distinction has a practical test. If the third party is given a screen and asked to fill it, that is capacity; if they are asked who should be spoken to, that is capability, and the firm has outsourced the judgment that makes its research distinctive. Most engagements sit somewhere between, and knowing which side of the line a scope falls on is worth establishing before it starts.
| In-house capacity | White-labeled | |
|---|---|---|
| Costs | Fixed, whether or not deals arrive | Variable, per engagement |
| Builds | Sector familiarity that compounds | Nothing that stays with you |
| Right when | Flow is steady and the sector is yours | Flow is lumpy or the sector is occasional |
Where do the economics cross?
At the utilization rate of a permanent researcher. Below roughly full occupancy across the year, permanent capacity costs more per delivered project than bought capacity does, and diligence demand is rarely smooth enough to reach that.
The crossover is therefore about demand variance rather than about volume. A practice with steady flow should build; one with lumpy flow should not.
Utilization is also harder to hold than a plan assumes, because diligence demand arrives in clusters rather than evenly. A researcher fully occupied on average can be idle for six weeks and over-committed for four, and the idle weeks are real cost while the over-committed ones are bought in anyway. Averaging the year hides both.
What does buying it cost you?
Sector familiarity. A team that has screened the same market three times knows who is worth speaking to, which questions get answered and which get deflected, and that knowledge does not transfer when the work is outsourced deal by deal — it is the bench that has to be kept current.
Where a practice intends to own a sector, that compounding is precisely what it is trying to build, and outsourcing it is the wrong economy.
The familiarity effect is also asymmetric across sectors. In a market a practice screens once, there is nothing to compound and buying is straightforwardly cheaper. In one it screens repeatedly, the compounding is the point, and the decision to outsource is really a decision about whether the practice intends to keep the sector.
How do you control quality?
By owning the screen and the discussion guide, and by reviewing transcripts rather than summaries. Those two controls preserve the parts of the work that determine whether the evidence is any good.
Reviewing summaries only is where outsourced research quietly degrades, because the summary reflects the writer's judgment about what mattered — the same objection that applies to reading someone else's transcript library.
Transcript review has a second benefit beyond quality control. It is how the commissioning team acquires the sector knowledge that would otherwise sit with the subcontractor, which means the control that protects the evidence also protects the compounding advantage. A practice that reads only summaries outsources both at once.
What do clients need to know?
Check the engagement terms — many require disclosure of subcontracted work, and that is a contractual question rather than a judgment one.
Beyond the contract, most clients care about who was interviewed and how the screen was defined, not about which organization placed the calls.